Treatment of Cholangiocarcinoma with a Humanized Anti-Claudin-1 Monoclonal Antibody. (October 2022) - Muller, M.; Nehme, Z.; Röhlen, N.; Juehling, F.; Crouchet, E.; Pessaux, P.; Felli, E.; Goyal, L.; Meyer, M.; Iacone, R.; Toso, A.; Bardeesy, N.; et al.